Infarmed withdraws batch of Salofalk intestinal inflammation medication from the market

The drug regulator (Infarmed) has ordered the immediate withdrawal of batch L25428A (expiry 11/2029) of Salofalk 3000mg granules due to serialization issues. Patients currently using medication from this specific batch are instructed not to stop treatment, but to contact their doctor as soon as possible for advice on a potential replacement.


